Synexa Life Sciences Overview
- Year Founded
-
2003
- Status
-
Private
- Employees
-
153
- Latest Deal Type
-
Debt - Acquisition
- Latest Deal Amount
-
$16.6M
- Investors
-
1
Synexa Life Sciences General Information
Description
Provider of biomarker and bioanalytical services intended to assist biotech companies in the development and analysis of biomarkers. The company's services comprise the identification, development, validation, analysis and interpretation of biomarker and bioanalytical readouts in translational or clinical research, enabling healthcare organizations to resolve challenging problems in new assay development and to get insights into the clinical pharmacology of drugs.
Contact Information
Website
www.synexagroup.comCorporate Office
- 32 Mendelweg
- Leiden Bioscience Park
- 2333 CS Leiden
- Netherlands
Corporate Office
- 32 Mendelweg
- Leiden Bioscience Park
- 2333 CS Leiden
- Netherlands
Synexa Life Sciences Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Debt - Acquisition | 01-Oct-2024 | $16.6M | Completed | Generating Revenue | ||
| 1. Later Stage VC | 01-Jan-2019 | Completed | Generating Revenue |
Synexa Life Sciences Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Synexa Life Sciences Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Synexa Life Sciences Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Gilde Healthcare | Venture Capital | Minority |
Synexa Life Sciences Acquisitions (2)
Synexa Life Sciences’s most recent deal was a Merger/Acquisition with Alderley Analytical. The deal was made on 07-Oct-2024.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Alderley Analytical | 07-Oct-2024 | Merger/Acquisition | Biotechnology | ||
| Syrinx Bioanalytics | 19-May-2022 | Merger/Acquisition | Laboratory Services (Healthcare) |
Synexa Life Sciences Affiliates
Subsidiaries (2)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Alderley Analytical | Macclesfield, United Kingdom | 2013 | |
| Syrinx Bioanalytics | Turku, Finland | 2007 |
Synexa Life Sciences FAQs
-
When was Synexa Life Sciences founded?
Synexa Life Sciences was founded in 2003.
-
Where is Synexa Life Sciences headquartered?
Synexa Life Sciences is headquartered in Leiden, Netherlands.
-
What is the size of Synexa Life Sciences?
Synexa Life Sciences has 153 total employees.
-
What industry is Synexa Life Sciences in?
Synexa Life Sciences’s primary industry is Biotechnology.
-
Is Synexa Life Sciences a private or public company?
Synexa Life Sciences is a Private company.
-
What is Synexa Life Sciences’s current revenue?
The current revenue for Synexa Life Sciences is .
-
Who are Synexa Life Sciences’s investors?
Gilde Healthcare has invested in Synexa Life Sciences.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
